The overexpression of CDK1 has been detected in several types of human cancers and contributes to deregulated cell cycle, DNA damage response, protein synthesis, and other cell cycle independent functions.[13] We next investigated whether CDK1 could phosphorylate USP29 and affect its tumor‐promoting function in TNBC. This evidence concerns the gene USP29 and neoplasm.